Stay updated with breaking news from Hematological Malignancies. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
NEWS RELEASE March 26, 2024 Vyxeos® Combination for I.V. Injection Receives Approval for the Treatment of High-risk...
IGI is introducing a pipeline of three oncology molecules currently undergoing clinical trials, targeting multiple myeloma, acute myeloid leukemia, and solid tumors.
Onward Therapeutics SA (Onward Therapeutics), a global biotechnology company focused on developing innovative immunotherapies for cancer treatment, today announced that the phase 1 clinical trial of OT-A201 (Study No. A20101), a first-in-class bispecific antibody targeting two immune checkpoints is in progress.
19.01.2024 - 26 different customers representing North America, Asia and Europe33 oral presentations across four consecutive days69 scientific posters will be featured in a virtual exhibition hallTopics span the application of optical genome mapping (OGM) in ...
Closing of Transaction with Pierre Fabre Laboratories to Expand Global Tab-cel® Partnership Tab-cel BLA on Track for Submission in Q2 2024 Following Positive New Data from Pivotal ALLELE...